Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0RK4K
|
|||
| Former ID |
DNC009114
|
|||
| Drug Name |
3-(3-Adamantan-1-yl-ureido)-benzoic acid
|
|||
| Synonyms |
CHEMBL478320; 3-(3-Adamantan-1-yl-ureido)-benzoic acid; SCHEMBL12932180; BDBM50267173; AKOS029868879; 3-(1-adamantylcarbamoylamino)benzoic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H22N2O3
|
|||
| Canonical SMILES |
C1C2CC3CC1CC(C2)(C3)NC(=O)NC4=CC=CC(=C4)C(=O)O
|
|||
| InChI |
1S/C18H22N2O3/c21-16(22)14-2-1-3-15(7-14)19-17(23)20-18-8-11-4-12(9-18)6-13(5-11)10-18/h1-3,7,11-13H,4-6,8-10H2,(H,21,22)(H2,19,20,23)
|
|||
| InChIKey |
IPTYXUOUPSNRTP-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Soluble epoxide hydrolase (EPHX2) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Arachidonic acid metabolism | |||
| Metabolic pathways | ||||
| Peroxisome | ||||
| Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
| WikiPathways | Metapathway biotransformation | |||
| Arachidonate Epoxygenase / Epoxide Hydrolase | ||||
| Arachidonic acid metabolism | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities. Bioorg Med Chem Lett. 2009 Mar 15;19(6):1784-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.